BRIEF published on 11/05/2026 at 14:53, 3 days 20 hours ago Formycon Adjusts 2026 Financial Outlook Amid Market Changes Adjusted EBITDA Formycon Market Competition 2026 Guidance FYB201 & FYB202
BRIEF published on 11/05/2026 at 14:53, 3 days 20 hours ago Formycon ajuste ses prévisions financières pour 2026 face à l'évolution du marché EBITDA Ajusté Formycon Concurrence Sur Le Marché Orientations Pour 2026 FYB201 Et FYB202
BRIEF published on 11/05/2026 at 14:49, 3 days 20 hours ago Formycon AG annonce des dépréciations d'actifs sans impact sur la trésorerie et revoit à la hausse ses prévisions d'EBITDA. Formycon AG Perspectives Financières Prévisions D'EBITDA FYB201 Et FYB202 Dépréciations Sans Incidence Sur La Trésorerie
BRIEF published on 11/05/2026 at 14:49, 3 days 20 hours ago Formycon AG Reports Non-Cash Impairments and Revises EBITDA Guidance EBITDA Guidance Formycon AG Financial Outlook Non-cash Impairments FYB201 And FYB202
PRESS RELEASE published on 11/05/2026 at 14:48, 3 days 20 hours ago Formycon maintains 2026 guidance for revenue, EBITDA and working capital, revises adjusted EBITDA and reassesses FYB201 and FYB202
PRESS RELEASE published on 11/05/2026 at 14:44, 3 days 20 hours ago EQS-Adhoc: Formycon AG recognizes non-cash impairments on FYB201 and FYB202 and revises its guidance for adjusted EBITDA
BRIEF published on 11/05/2026 at 06:35, 4 days 5 hours ago Formycon AG Hosts Conference Call and Attends Investor Conferences Investor Conferences Formycon AG Biosimilars Financial Outlook Nine-month Results
BRIEF published on 11/05/2026 at 06:35, 4 days 5 hours ago Formycon AG organise une conférence téléphonique et participe à des conférences pour les investisseurs. Formycon AG Conférences D'investisseurs Perspectives Financières Biosimilaires Résultats À Neuf Mois
PRESS RELEASE published on 11/05/2026 at 06:30, 4 days 5 hours ago Formycon invites to conference call on 2026 nine-month results and announces participation in international investor conferences
BRIEF published on 11/03/2026 at 14:52, 5 days 20 hours ago Formycon AG's Keytruda Biosimilar Gains FDA Acceptance Formycon AG Market Entry FYB206 Keytruda Biosimilar FDA Acceptance
Published on 11/06/2026 at 22:15, 2 days 13 hours ago Jaguar Health Reports Approval of All Proposals at November 2026 Special Meeting of Stockholders
Published on 11/06/2026 at 13:00, 2 days 22 hours ago Alaska Energy Metals Achieves High Extraction Rates of Metals from Hydromet Testing, Nikolai Nickel Project, Alaska
Published on 11/06/2026 at 12:30, 2 days 23 hours ago Relevant Gold Receives Expanded Drilling Approvals for the Lewiston Project in Wyoming
Published on 11/06/2026 at 12:30, 2 days 23 hours ago Vogenx Reports Third Quarter 2026 Financial Results and Business Highlights
Published on 11/09/2026 at 11:05, 32 minutes ago Velvet, mirrors and rooms upstairs: inside Lisbon's Pensão Amor
Published on 11/09/2026 at 11:05, 32 minutes ago THE 50 BEST VINEYARDS REVEALS THE 51-100 LIST FOR 2026
Published on 11/09/2026 at 11:00, 37 minutes ago LINXAI Robotics Claims Gold and Two Bronzes at First CMG World Robot Mount Tai Competition
Published on 11/09/2026 at 10:55, 42 minutes ago Huawei Recognized as a Leader in the 2026 Gartner® Magic Quadrant™ for Infrastructure Platform Consumption Services
Published on 11/09/2026 at 10:32, 1 hour 5 minutes ago Disclosure of shares outstanding and voting rights - 09.11.2026
Published on 11/09/2026 at 10:32, 1 hour 5 minutes ago Déclaration nombre d'actions et droits de vote - 09.11.2026
Published on 11/09/2026 at 07:00, 4 hours 37 minutes ago bioMérieux receives U.S. FDA 510(k) clearance for the latest versions of the BIOFIRE® FILMARRAY® Gastrointestinal Panels to enhance detection of gastrointestinal pathogens including norovirus
Published on 11/09/2026 at 07:00, 4 hours 37 minutes ago BIOPHYTIS ANNOUNCES THE OPERATIONAL LAUNCH OF ITS JOINT VENTURE IN CHINA
Published on 11/09/2026 at 07:00, 4 hours 37 minutes ago Biophytis annonce le démarrage opérationnel de sa co-entreprise en Chine
